Wei Tao, Ph.D., is a Silicon Valley based investor focusing on early stage life science and technology companies with explosive growth potential, commercializing disruptive technology and products addressing large growing unmet needs. Dr. Tao currently chairs the LSA Bio/Genomics Committee and the SHA Deal Sourcing & Syndication Committee. Dr. Tao is a sought-after value-add investor, speaker and adviser. He deeply engages entrepreneurial community in Silicon Valley and beyond. Dr. Tao is an adviser to a number of entrepreneurship initiatives at leading institutions such as Stanford University, UC Berkeley and UCSF. He serves on the Board of Directors at LSA and SHA, as well as at several venture-backed companies.
Wei is attending / has attended:
Venture Summit | West 2019